Nephroprotective Effects of Cilastatin in People at Risk of Acute Kidney Injury: A Systematic Review and Meta-analysis
Published in the peer-reviewed journal of the National Kidney Foundation, Kidney Medicine (December 2024), this meta-analysis led by Dr. Matthew T. James and colleagues systematically reviewed human clinical data evaluating cilastatin’s potential nephroprotective effects in people at risk of acute kidney injury (AKI). The study supports the clinical rationale for cilastatin, a well-established inhibitor of … Read more